HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Coagulation factor VII activity, Arg/Gln353 polymorphism and features of insulin resistance in first-degree-relatives of South Asian patients with stroke.

Abstract
The aim of the study was to determine associations of factor VII:C levels in 140 South Asian stroke subjects and 143 first-degree relatives versus age-sex matched 146 control subjects without a personal or a family history of stroke subjects living in UK. There were no significant differences in Factor VII:C levels or FVII Msp I gene polymorphism (Arg-Gln 353) R353Q genotype frequency between the groups. R353Q genotype determined Factor VII:C levels in all the three groups. Factor VII:C levels correlated with triglycerides (patients, r = 0.23; relatives r = 27; control subjects, r = 0.24) and plasminogen activator inhibitor activity (patients, r = 0.30; relatives r = 0.22; control subjects r = 0.20) in all the three groups, but with insulin only in patients (p = 0.19). Circulating levels of Factor VII:C are determined by R353Q genotype and cluster with other risk factors associated with insulin resistance in South Asian ischaemic stroke patients, first-degree relatives and control subjects but are not related to stroke or a family history of stroke.
AuthorsKirti Kain, Andrew J Catto, John Young, John Bamford, John Bavington, Peter J Grant
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 88 Issue 6 Pg. 954-60 (Dec 2002) ISSN: 0340-6245 [Print] Germany
PMID12529745 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens
  • factor VII clotting antigen
  • Factor VII
  • DNA
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Antigens (blood)
  • Asia
  • Base Sequence
  • Case-Control Studies
  • DNA (genetics)
  • Factor VII (genetics)
  • Female
  • Gene Frequency
  • Humans
  • Insulin Resistance
  • Male
  • Middle Aged
  • Polymorphism, Genetic
  • Risk Factors
  • Stroke (blood, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: